Innospec Inc. (NASDAQ:IOSP) Given Average Recommendation of “Hold” by Brokerages

Innospec Inc. (NASDAQ:IOSP) has been assigned a consensus rating of “Hold” from the three analysts that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation and one has given a strong buy recommendation to the company.

IOSP has been the subject of a number of research reports. Weiss Ratings downgraded Innospec from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Saturday, October 25th. Zacks Research lowered Innospec from a “hold” rating to a “strong sell” rating in a research note on Tuesday. Finally, Wall Street Zen cut Innospec from a “buy” rating to a “hold” rating in a research report on Sunday, October 19th.

Institutional Trading of Innospec

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Nisa Investment Advisors LLC lifted its stake in Innospec by 8.8% during the third quarter. Nisa Investment Advisors LLC now owns 1,917 shares of the specialty chemicals company’s stock worth $148,000 after purchasing an additional 155 shares during the period. State of Wyoming raised its holdings in shares of Innospec by 27.5% in the 2nd quarter. State of Wyoming now owns 801 shares of the specialty chemicals company’s stock worth $67,000 after buying an additional 173 shares in the last quarter. California State Teachers Retirement System lifted its position in shares of Innospec by 0.8% during the 2nd quarter. California State Teachers Retirement System now owns 23,062 shares of the specialty chemicals company’s stock worth $1,939,000 after buying an additional 179 shares during the period. Blue Trust Inc. boosted its stake in Innospec by 38.3% in the 2nd quarter. Blue Trust Inc. now owns 672 shares of the specialty chemicals company’s stock valued at $57,000 after buying an additional 186 shares in the last quarter. Finally, US Bancorp DE boosted its stake in Innospec by 4.2% in the 1st quarter. US Bancorp DE now owns 5,082 shares of the specialty chemicals company’s stock valued at $482,000 after buying an additional 207 shares in the last quarter. Institutional investors own 96.64% of the company’s stock.

Innospec Stock Performance

NASDAQ:IOSP opened at $73.49 on Friday. The firm’s 50-day moving average is $78.43 and its 200-day moving average is $83.38. The company has a market cap of $1.82 billion, a price-to-earnings ratio of 94.22 and a beta of 1.06. Innospec has a 52-week low of $71.06 and a 52-week high of $124.80.

Innospec (NASDAQ:IOSP) last released its earnings results on Tuesday, November 4th. The specialty chemicals company reported $1.12 earnings per share for the quarter, beating the consensus estimate of $1.03 by $0.09. Innospec had a net margin of 1.08% and a return on equity of 10.89%. The business had revenue of $441.90 million during the quarter, compared to analysts’ expectations of $443.00 million. During the same quarter last year, the company earned $1.35 earnings per share. The firm’s revenue was down .3% on a year-over-year basis. Equities analysts predict that Innospec will post 6.18 EPS for the current year.

Innospec Announces Dividend

The firm also recently disclosed a dividend, which will be paid on Wednesday, November 26th. Stockholders of record on Tuesday, November 18th will be issued a dividend of $0.87 per share. This represents a dividend yield of 237.0%. The ex-dividend date of this dividend is Tuesday, November 18th. Innospec’s dividend payout ratio (DPR) is presently 215.38%.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.